Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
This research is a prospective, randomized, cross-over study that is being done to compare
the effect of morning only, evening only and twice daily insulin glargine (Lantus®) on
hypoglycemia (blood glucose level <70 mg/dL) as measured by continuous glucose monitoring
(CGM) in patients with type 1 diabetes.